Literature DB >> 27072638

Hydrophilic polymer embolism: past obstacles and future progress.

Rashi I Mehta1, Rupal I Mehta2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27072638      PMCID： PMC4920131          DOI： 10.1016/j.humpath.2016.02.030

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  5 in total

1.  Hydrophilic polymer embolism: an underrecognized iatrogenic cause of ischemia, inflammation, and coagulopathy.

Authors:  Rupal I Mehta; Rashi I Mehta; Youngjae Chun
Journal:  Hum Pathol       Date:  2014-12-31       Impact factor: 3.466

2.  Hydrophilic polymer emboli: an under-recognized iatrogenic cause of ischemia and infarct.

Authors:  Rupal I Mehta; Rashi I Mehta; Orestes E Solis; Reza Jahan; Noriko Salamon; Jonathan M Tobis; William H Yong; Harry V Vinters; Michael C Fishbein
Journal:  Mod Pathol       Date:  2010-03-19       Impact factor: 7.842

3.  Hydrophilic polymer embolism and associated vasculopathy of the lung: prevalence in a retrospective autopsy study.

Authors:  Rupal I Mehta; Rashi I Mehta; Julia M Choi; Arnob Mukherjee; Rudy J Castellani
Journal:  Hum Pathol       Date:  2014-10-07       Impact factor: 3.466

4.  Intravascular polymer material after coil embolization of a giant cerebral aneurysm.

Authors:  Rupal I Mehta; Rashi I Mehta; Michael C Fishbein; Orestes E Solis; Reza Jahan; Noriko Salamon; Harry V Vinters; William H Yong
Journal:  Hum Pathol       Date:  2009-08-27       Impact factor: 3.466

Review 5.  Polymer-induced central nervous system complications following vascular procedures: spectrum of iatrogenic injuries and review of outcomes.

Authors:  Rashi I Mehta; Rupal I Mehta
Journal:  Hum Pathol       Date:  2016-04-09       Impact factor: 3.466
  5 in total
  1 in total

Review 1.  Hydrophilic Polymer Embolism: Implications for Manufacturing, Regulation, and Postmarket Surveillance of Coated Intravascular Medical Devices.

Authors:  Rashi I Mehta; Rupal I Mehta
Journal:  J Patient Saf       Date:  2021-12-01       Impact factor: 2.844
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.